首页|益肾化瘀方辅助治疗对不明原因复发性流产患者辅助性T细胞17/调节性T细胞平衡及雌孕激素的影响

益肾化瘀方辅助治疗对不明原因复发性流产患者辅助性T细胞17/调节性T细胞平衡及雌孕激素的影响

扫码查看
目的 观察益肾化瘀方辅助治疗对不明原因复发性流产(URSA)患者辅助性T细胞17(Th17)/调节性T细胞(Treg)平衡及雌孕激素的影响.方法 将92 例URSA患者按照随机数字表法分为2 组,对照组46 例予西医常规治疗,治疗46 例在对照组基础上联合益肾化瘀方治疗,连续治疗至孕 12 周.比较 2 组中医证候积分、Th17/Treg细胞水平、Th17 和Treg相关细胞因子[白细胞介素17A(IL-17A)、白细胞介素35(IL-35)、转化生长因子β1(TGF-β1)]、雌孕激素[血清雌二醇(E2)、孕酮(P)、β人绒毛膜促性腺激素(β-HCG)]水平、中医证候疗效、保胎成功率.结果 治疗组总有效率96.65%(44/46),对照组总有效率82.61%(38/46),治疗组高于对照组(P<0.05).2 组治疗后中医证候各项评分及总分均较本组治疗前降低(P<0.05),且治疗组治疗后均低于对照组(P<0.05).2 组治疗后 Th17 细胞、Th17/Treg均较本组治疗前降低(P<0.05),Treg细胞均升高(P<0.05),且治疗组治疗后Th17 细胞、Th17/Treg均低于对照组(P<0.05),Treg 细胞高于对照组(P<0.05).2 组治疗后血清 IL-17A 均较本组治疗前降低(P<0.05),IL-35、TGF-β1 均升高(P<0.05),且治疗组治疗后血清IL-17A水平低于对照组(P<0.05),IL-35、TGF-β1 水平均高于对照组(P<0.05).2 组治疗后血清E2、P、β-HCG均较本组治疗前升高(P<0.05),且治疗组治疗后E2、P、β-HCG均高于对照组(P<0.05).治疗组保胎成功率 84.78%(39/46),对照组 65.22%(30/46),治疗组高于对照组(P<0.05).结论 益肾化瘀方辅助治疗能够改善URSA临床症状,提高保胎成功率,可能与纠正Th17/Treg平衡失调、促进雌孕激素分泌等因素有关.
Effect of Yishen Huayu Prescription on Th17/Treg cell balance and estrogen-progestogen in patients with unexplained recurrent spontaneous abortion
Objective To study the effect of Yishen Huayu Prescription on T helper cell 17(Th17)/regulatory T(Treg)cell balance and estrogen-progesterone in patients with unexplained recurrent spontaneous abortion(URSA).Methods Ninety-two patients with URSA were randomly divided into treatment group(46 cases)and control group(46 cases).All pa-tients were given routine Western medicine(RWM),those in the treatment group were additionally given Yishen Huayu Prescrip-tion.A 12-week treatment was performed in both groups.The traditional Chinese medicine(TCM)syndrome score,Th17/Treg cells level,Th17/Treg related cytokines levels(Interleukin-17A[IL-17A],IL-35,transforming growth factor-β1[TGF-β1]),female hormone level(estradiol[E2],progesterone[P],β-human chorionic gonadotropin[β-HCG]),curative effect of TCM syndrome,the success rate of fetal protection were included as comparators between groups.Results The total ef-fective ratein the treatment group was significantly higher than that of control group(95.65%[44/46]vs 82.61%[38/46],P<0.05).After treatment,the dimension score and total score of TCM syndrome in the both groups were significantly lower than those before treatment,and the decreases were more common in the treatment group relative to the control group(P<0.05).After treatment,Th17 cells and Th17/Treg in the both groups were sig-nificantly lower than those before treatment,while Treg cells was significantly higher(P<0.05),and the treatment group was su-perior to the control group for the levels of Th17 cells,Th17/Treg,Treg cells.After treatment,IL-17A in the two groups was significantly lower than that before treatment(P<0.05),while IL-35 and TGF-β1 were significantly higher(P<0.05).There were significant differences in serum levelsof IL-17A,IL-35 and TGF-β1 between the treatment group and the control group after treatment(P<0.05).E2,P,β-HCG in the both groups were significantly higher than those before treatment,the increases were more pronounced in the treatment group compared to the control group(P<0.05).The success rate of fetal pro-tection in the treatment group was significantly higher than that of control group(84.78%[39/46]vs 65.22%[30/46],P<0.05).Conclusion Yishen Huayu Prescription in treating URSA can improve the clinical symptoms and therapy effect,which may promote secretion of estrogen-progesterone by correcting Th17/Treg cell imbalance.

Unexplained recurrent spontaneousabortionTraditional Chinese medicine therapyTh17/Treg cellsEstro-gen-progestogen

曹天澈、刘德佩、陈聪

展开 >

江苏省南京市中西医结合医院妇产科,江苏 南京 210014

江苏省中医院妇科,江苏 南京 210009

不明原因复发性流产 中药疗法 Th17/Treg 雌孕激素

江苏省卫生计生委项目

F201667

2024

河北中医
河北省医学情报研究所,河北省中医药学会

河北中医

CSTPCD
影响因子:0.951
ISSN:1002-2619
年,卷(期):2024.46(5)